centene chief medical officer centene chief medical officer

Since joining Centene in 2006, he has overseen the development and implementation of new health plans in more than 25 states, provided strategic guidance to state governments to help them develop effective Medicaid solutions, and developed new business contracting with providers and health systems where he led the company's effort in value-based purchasing. Dr. Chen is responsible for Centene's strategies, policies, and programs in support of improving population health for Centene's members. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology. At Humana Mr. Fasola was the COO of Market Operations and formerly a member of the Office of the Chairman, a role he assumed after thirteen years leading various divisions within the company. Learn how Chief Medical Officer for Wellcare in Kentucky, Dr. Sandra Guerra, has worked to reach Hispanic communities during the COVID-19 pandemic to promote the importance of vaccines. Transforming the health of the community, one person at a time. Centenefocuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. With extensive leadership and more than 20 years of experience in the managed care industry, Mr. Thomas will take on an expanded scope and responsibility for the Medicaid product and business development. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. los inconvenientes que esto te pueda causar. Founded in 1933 and based in Eugene, OR, with offices in Oregon, Idaho and Montana, PacificSource serves ~ 260,000 members (Commercial . A: I didnt. envie um e-mail para Previously, he was President and COO for Magellan Health where he oversaw the Magellan Behavioral and Specialty Health and Magellan Complete Care business segments. This Hispanic Heritage Month, were highlighting the contributions of Hispanic and Latinx medical directors and chief medical officers across Centene health plans. It gives her an opportunity to speak to the Hispanic community about a vital issue, directly discussing her familys own experiences. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/. He served as CEO of Secure Horizons, a division of UnitedHealth Group and the nation's largest Medicare Advantage insurer. Dr. Yamaguchi received a dose of the vaccine at Barnes-Jewish Hospital in St. Louis, Missouri (pictured). Dr. Chen received a Bachelor of Science in Environmental Biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Centene Board of Directors. Dr. Patel has more than 18 years of healthcare experience and has served in leadership roles. David P. Thomas, CEO, Markets and Medicaid, Centene Corporation. Most COVID-19 vaccines require two injections; the first starts building protection and the second is given a few weeks later. Ken Fasola, currently Executive Vice President (EVP) of Health Care Enterprises, will become President of Centene, continuing to report to Sarah London. removing social barriers to health, and prioritizing responsible message, please email In his role as President, Mr. Fasola brings more than three decades of successful leadership in the healthcare industry, including CEO roles at multiple health insurance companies. Chief Health Officer. Medical professionals have sometimes stayed away from non-traditional media, Dr. Guerra said. Thank you, Rocco, and good morning, everyone. The health of individuals drives our focus on the environment, Average Centene Chief Medical Officer yearly pay in the United States is approximately $306,170, which is 28% above the national average. Centene.com uses cookies. Prior to Optum Ventures, Ms. London served as Chief Product Officer for Optum Analytics, the business unit responsible for driving strategy and commercialization of Optum's integrated data and analytics solutions into the provider, payer and life sciences markets. Alex Chen is chief medical officer at Health Net, LLC. Additionally, the Company announced the appointment of Alice H. Chen, MD, MPH, as Chief Health Officer (CHO), effective January 1, 2023, and Brian LeClaire, MBA, PhD, as Chief Information Officer (CIO), effective December 5, 2022. The phased approach addresses and prioritizes vaccination for healthcare workers, people in long-term care facilities, and certain groups of essential workers and first responders. Mr. Layton received his bachelor's degree from the University of Georgia. Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. Dave Thomas most recently served as Centene's Executive Vice President, Markets where he was responsible for the oversight of Centene's 31 health plans nationwide. Dr. Chen received a Bachelor of Science in Environmental Biology from Yale University and has a Doctor of Medicine from the Stanford University School of Medicine. Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Q: Did you experience any side effects or complications from the vaccine? Brent Layton has more than 30 years of experience with increasing responsibility in the healthcare and public policy sectors, with particular expertise in creating, scaling, and operating business in a highly regulated environment. This list of important factors is not intended to be exhaustive. Si continas recibiendo este mensaje, infrmanos del problema "Additionally, we are excited to welcome two new leaders to our senior management team. I'm thrilled to be part of this management team, and I firmly believe in the potential of this Company to continue its remarkable history of accomplishment within the healthcare industry.". Centene said it net income increased 33% year-over-year, to $1.13 billion, or $2.11 earnings per share, on revenues of $38.8 billion, driven by increased exchange revenue and lower medical expenses. Aydanos a proteger Glassdoor y demustranos que eres una persona real. Mr. Thomas received a bachelor's degree in Sociology from the University at Albany and a Master of Business Administration from the Zicklin School of Business at Baruch College in Manhattan. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Please enable Cookies and reload the page. Murray also served as Executive Vice President and Chief Operating Officer for Humana and held other significant leadership roles over a career spanning nearly three decades. Even after being vaccinated its important to follow all the expected CDC-recommended safety procedures. Centene.com uses cookies. 3K followers 500+ connections. Ken Fasola, President, Centene Corporation. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs. Michael built one of the great success stories in American business, and his commitment to providing affordable, high-quality healthcare to our fellow citizens will remain a bedrock of this Company going forward," said Ms. London. Centeneoffers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by theHealth Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Please help us protect Glassdoor by verifying that you're a Ajude-nos a manter o Glassdoor seguro confirmando que voc uma pessoa de This is normal as your body builds immunity and fights off future COVID-19 exposures. As CIO, Mr. LeClaire will be responsible for Centene's information technology strategy, ensuring its alignment with the Company's business strategy, and delivering secure, differentiated technology-enabled experiences to members. Chief Medical Officer, Pharmacy, Innovation Merritt Island, Florida, United States. Centene.com uses cookies. As CHO, Dr. Chen will be responsible for Centene's strategies, policies, and programs in support of improving population health for Centene's more than 26 million members. If you experience a severe reaction, contact your healthcare provider or visit the Vaccine Adverse Event Reporting System. Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality, equity, and delivery system transformation. Onze Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and in her management role was responsible for a portfolio of companies independent of Centene's health plans, designing differentiated platform capabilities, and delivering industry-leading products and services to third-party customers. enva un correo electrnico a Prior to joining Centene, Dr. Chen was Chief Medical Officer at Covered California, the state's health insurance marketplace, where she was responsible for healthcare strategy focused on quality . Magna Cum Laude in History & Literature from Harvard College, where she played Division I tennis. and Terms and She also has a Master of Public Health in Health Care Management and Policy from Harvard School of Public Health. He leads GCHP's quality improvement, utilization management, care management, disease management, health education, and pharmacy teams. Our local approach allows us to help members access high-quality, culturally sensitive Executive Vice President of External Affairs. Alice Hm Chen, MD, MPH, serves as Chief Health Officer (CHO) for Centene Corporation. Additionally, the Company announced the appointment of Alice H. Chen, MD, MPH, as Chief Health Officer (CHO), effective January 1, 2023, and Brian LeClaire, MBA, PhD, as Chief Information Officer (CIO), effective December 5, 2022. He joined Centene through the acquisition of Magellan Health Inc (MGLN) where he served as CEO and a member of the Board of Directors. ST. LOUIS, Dec. 14, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today leadership changes and senior management appointments to position the Company for its next stage of growth. A: Healthcare personnel continue to be on the front line of our country's battle against COVID-19. Centene Corporation, a Fortune 25 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. Ken Yamaguchi, MD, MBA, retired from Centene Corporation in June of 2022 after 7 years as an Executive Vice President, Chief Medical Officer. om ons te informeren over dit probleem. Our local approach allows us to help members access high-quality, culturally sensitive naar The estimated total pay for a Chief Medical Officer at Centene is $310,340 per year. I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". Centenefocuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners. Caso continue recebendo esta mensagem, The Company also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. ST. LOUIS, April 27, 2015 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced the appointment of Ken Yamaguchi, M.D., to Executive Vice President and Chief Medical Officer, effective . Our medical directors play vital roles in everything from case review to acting as spokespersons advocating for healthy behaviors to shape and promote initiatives that improve the health of millions of members. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. Our local approach allows us to help members access high-quality, culturally sensitive healthcare services. 4 C Medical Group. Wenn The public and private sectors want the same thing to improve healthcare, said Dr. Guerra. In her management role, Ms. London led the Company's technology and digital strategy in addition to running the Health Care Enterprises and Specialty divisions, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Risk Management. Previously he served as Senior Vice President and Chief Information Officer for Humana, where he spent more than two decades in various technology and operational leadership roles. St. Louis, MO 63105 NOTE: Centene Corporation is the parent company of Buckeye Health Plan, Inc. Chief Medical Officer at Centene-Absolute Total Care Columbia, South Carolina, United States. Ken Fasola named President of Centene Jim Murray named Chief Operating Officer Brent Layton becomes Senior Advisor to the CEO Dave Thomas becomes Chief Executive Officer of Markets and. As practicing physicians, our medical directors stay up to date on the best treatments and practices while understanding the needs of our members and those of the community. "With these appointments, Centene is aligning the outstanding talent within our senior executive team with the Company's value creation mission and long-term strategy for growth," said Centene Chief Executive Officer (CEO) Sarah London. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. In this role, Dr. Chen leads and provides oversight of Health Net teams responsible for the Medical Affairs & Quality department. Over the next year, Mr. Layton will continue to play a pivotal role in developing and expanding key strategic partnerships for Centene and driving the Company's business development strategy. Chief Medical Officer. Dr. Chen was also a professor of medicine at the University of California San Francisco School of Medicine, based at the Zuckerberg San Francisco General Hospital, where she served as its Chief Integration Officer and founding director of the eConsult program. The CDC's recommendations for individuals eligible for the initial phases of COVID-19 vaccination are below: The phased approach addresses and prioritizes vaccination for healthcare workers, people in long-term care facilities, and certain groups of essential workers and first responders. Innovations & Initiatives, Health & Wellness. Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the ongoing impact of COVID-19; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the acquisition of Magellan Health, Inc. (the Magellan Acquisition); the possibility that the expected synergies and value creation from the Magellan Acquisition or the acquisition of WellCare Health Plans, Inc. (the WellCare Acquisition) (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition; unexpected costs, or similar risks, from other acquisitions or dispositions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; the risk that the closing conditions, including applicable regulatory approvals, for the pending disposition of Magellan Specialty Health may be delayed or not obtained; impairments to real estate, investments, goodwill and intangible assets; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the current administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price and accretion for acquisitions or dispositions; restrictions and limitations in connection with our indebtedness; the availability of debt and equity financing on terms that are favorable to us; inflation; foreign currency fluctuations; and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. an. Brent Layton, Senior Advisor to CEO, Centene Corporation. Ci Prior to that he was a Vice President of Product Development at Alltel, a wireless service provider acquired by Verizon Wireless. Jim Murray, EVP, Chief Operating Officer, Centene Corporation. Mr. Thomas received a bachelor's degree in Sociology from the University at Albany and a Master of Business Administration from the Zicklin School of Business at Baruch College in Manhattan. At Arsenal, he led information technology due diligence, advisory and oversight for the firm's healthcare sector, and aided portfolio companies in the development and delivery of their technology strategy and value capture initiatives. Together, today's appointments reinforce and accelerate Centene's longstanding commitment to providing high-quality, low-cost healthcare to members and increasing value to shareholders.". Join to view profile Centene-Maryland Physicians Care . Dr. Ken Yamaguchi, Centene Executive Vice President & Chief Medical Officer, has firsthand experience with the COVID-19 vaccine. Over the next year, Mr. Layton will continue to play a pivotal role in developing and expanding key strategic partnerships for Centene and driving the Company's business development strategy. Centene.com uses cookies. PacificSource Health Plans. LOUIS, March 22, 2022 / PRNewswire / -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. By continuing to use our site, you agree to our Privacy Policy and Terms and Conditions. As the vaccine supply increases, vaccination will be available for additional segments of the population. This list of important factors is not intended to be exhaustive. This list of important factors is not intended to be exhaustive. Conditions. Centene Corporation About Dr. Alice Hm Chen is chief health office for Centene, the largest Medicaid and Marketplace managed care organization in the U.S., where she is responsible for. Ms. London previously served as the Company's Senior Vice President of Technology Innovation and Modernization, responsible for enterprise-wide technology strategy and execution with a focus on next-generation products and services. She previously served as Deputy Secretary for Policy and Planning and Chief of Clinical Affairs for the California Health and Human Services Agency, where she led signature health policy initiatives on affordability and access and played a leadership role in the state's response to the COVID-19 pandemic. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments and the adequacy of our available cash resources. In her new . Wir entschuldigen uns fr die Umstnde. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. Dr. Ken Yamaguchi, Centene Executive Vice President & Chief Medical Officer, has firsthand experience with the COVID-19 vaccine. All forward-looking statements included in this press release are based on information available to us on the date hereof. Transforming Communities, Health & Wellness. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. We are implementing targeted efforts to stratify and identify our members that are candidates for vaccination, provide outreach to help them access vaccination including transportation when appropriate, and provide follow-up to ensure the second vaccine doses are received in a timely manner. Prior to joining Centene, Brian LeClaire was Director, Technology, for the healthcare team at Arsenal Capital Partners, a private equity firm specializing in investments in healthcare and industrial growth companies. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well. By continuing to use our site, you agree to our Privacy Policy A: My routine wont change. ", "I am honored and humbled to have been selected as the next CEO of Centene and to work alongside extraordinary colleagues to provide quality healthcare to over 26 million Americans," said Ms. London. Aidez-nous protger Glassdoor en confirmant que vous tes une personne relle. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. questo messaggio, invia un'email all'indirizzo The health of individuals drives our focus on the environment, removing social barriers to health, and prioritizing . We are sorry for the inconvenience. Als u dit bericht blijft zien, stuur dan een e-mail Ms. London received an M.B.A. with High Honors from the University of Chicago Booth School of Business and a B.A. Previously he served as Senior Vice President and Chief Information Officer for Humana, where he spent more than two decades in various technology and operational leadership roles. Thank you for joining us on our first quarter earnings results conference call. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.